You are using a version of the website built for webcrawlers and people whose devices cannot use javascript.
Some functionality will not be available.
Contents (2001 - 648)
Skip to content
Occupational Health and Safety Regulation 2001
Repealed version for 7 June 2011 to 31 December 2011 (accessed 21 September 2019 at 06:56)
Chapter 7 Part 7.6 Clause 202
202   Biological monitoring and health surveillance
(1)  In the case of lead risk work, any biological monitoring required to be performed under Part 6.4 must consist of the measurement of lead in whole blood or packed red cells, sampled as capillary or venous blood (as appropriate) and related measurements, as required.
(2)  In the case of lead risk work, health surveillance (additional to that required to be performed under Part 6.4) must be performed:
(a)  in relation to an employee who is carrying out lead risk work at 1 September 2001—as soon as practicable after that date, or
(b)  in relation to an employee who commences lead risk work after 1 September 2001:
(i)  before the employee commences the work (except biological monitoring), and
(ii)  within one month of the commencement of the work, and
(iii)  as soon as practicable after 2 months of the commencement of the work, and
(iv)  as soon as practicable after 6 months of the commencement of the work.
(3)  In the case of lead risk work, the biological monitoring required to be performed under Part 6.4 and subclause (1) must be performed at the following intervals:
(a)  for females of reproductive capacity:
(i)  within 3 months of the last biological monitoring if the result of that last monitoring shows a blood lead level of less than 0.48 µmol/L (10 µg/dL), or
(ii)  within 6 weeks of the last biological monitoring if the result of the last monitoring shows a blood lead level result of 0.48 µmol/L (10 µg/dL) or more,
(b)  for females not of reproductive capacity and males:
(i)  within 6 months of the last biological monitoring if the result of the last monitoring shows a blood lead level result of less than 1.45 µmol/L (30 µg/dL), or
(ii)  within 3 months of the last biological monitoring if the result of the last monitoring shows a blood lead level of 1.45 µmol/L (30 µg/dL) or more but less than 1.93 µmol/L (40 µg/dL), or
(iii)  within 6 weeks of the last biological monitoring if the result of the last monitoring shows a blood lead level of 1.93 µmol/L (40 µg/dL) or more.
Maximum penalty: Level 4.